BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 12580930)

  • 1. Diagnosis of growth hormone deficiency after pituitary surgery: the combined acipimox/GH-releasing hormone test.
    van Dam PS; Dieguez C; Cordido F; de Vries WR; Veldhuyzen BF; van Thiel E; Casanueva FF; Koppeschaar HP
    Clin Endocrinol (Oxf); 2003 Feb; 58(2):156-62. PubMed ID: 12580930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between insulin tolerance test, growth hormone (GH)-releasing hormone (GHRH), GHRH plus acipimox and GHRH plus GH-releasing peptide-6 for the diagnosis of adult GH deficiency in normal subjects, obese and hypopituitary patients.
    Cordido F; Alvarez-Castro P; Isidro ML; Casanueva FF; Dieguez C
    Eur J Endocrinol; 2003 Aug; 149(2):117-22. PubMed ID: 12887288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism.
    Cordido F; Fernandez T; Martinez T; Peñalva A; Peinó R; Casanueva FF; Dieguez C
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4350-4. PubMed ID: 9851776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-assessment of growth hormone secretion in young adult patients with childhood-onset growth hormone deficiency.
    Donaubauer J; Kiess W; Kratzsch J; Nowak T; Steinkamp H; Willgerodt H; Keller E
    Clin Endocrinol (Oxf); 2003 Apr; 58(4):456-63. PubMed ID: 12641629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divergence between growth hormone responses to insulin-induced hypoglycaemia and growth hormone-releasing hormone in patients with non-functioning pituitary macroadenomas and hyperprolactinaemia.
    Beentjes JA; Tjeerdsma G; Sluiter WJ; Dullaart RP
    Clin Endocrinol (Oxf); 1996 Oct; 45(4):391-8. PubMed ID: 8959076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of acute reduction of free fatty acids by acipimox on growth hormone-releasing hormone-induced GH secretion in type 1 diabetic patients.
    Alvarez P; Isidro L; Peinó R; Leal-Cerro A; Casanueva FF; Dieguez C; Cordido F
    Clin Endocrinol (Oxf); 2003 Oct; 59(4):431-6. PubMed ID: 14510904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of acute pharmacological modulation of plasma free fatty acids on GH secretion in acromegalic patients.
    Cordido F; Peñalva A; Martinez T; Casanueva FF; Dieguez C
    Clin Endocrinol (Oxf); 2001 Apr; 54(4):509-13. PubMed ID: 11318787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone releasing hormone plus arginine stimulation testing in young adults treated in childhood with cranio-spinal radiation therapy.
    Ham JN; Ginsberg JP; Hendell CD; Moshang T
    Clin Endocrinol (Oxf); 2005 May; 62(5):628-32. PubMed ID: 15853837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency.
    Biller BM; Samuels MH; Zagar A; Cook DM; Arafah BM; Bonert V; Stavrou S; Kleinberg DL; Chipman JJ; Hartman ML
    J Clin Endocrinol Metab; 2002 May; 87(5):2067-79. PubMed ID: 11994342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The usefulness of the combined growth hormone (GH)-releasing hormone and arginine stimulation test in the diagnosis of radiation-induced GH deficiency is dependent on the post-irradiation time interval.
    Darzy KH; Aimaretti G; Wieringa G; Gattamaneni HR; Ghigo E; Shalet SM
    J Clin Endocrinol Metab; 2003 Jan; 88(1):95-102. PubMed ID: 12519836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term administration of acipimox potentiates growth hormone response to growth hormone-releasing hormone by decreasing serum free fatty acid in obesity.
    Nam SY; Lee ; Kim KR; Lee HC; Nam MS; Cho JH; Huh KB
    Metabolism; 1996 May; 45(5):594-7. PubMed ID: 8622602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acipimox potentiates growth hormone response to growth hormone-releasing hormone by decreasing serum free fatty acid levels in hyperthyroidism.
    Lee EJ; Kim KR; Lee HC; Cho JH; Nam MS; Nam SY; Song YD; Lim SK; Huh KB
    Metabolism; 1995 Nov; 44(11):1509-12. PubMed ID: 7476342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults.
    Popovic V; Leal A; Micic D; Koppeschaar HP; Torres E; Paramo C; Obradovic S; Dieguez C; Casanueva FF
    Lancet; 2000 Sep; 356(9236):1137-42. PubMed ID: 11030292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acipimox-mediated plasma free fatty acid depression per se stimulates growth hormone (GH) secretion in normal subjects and potentiates the response to other GH-releasing stimuli.
    Peino R; Cordido F; Peñalva A; Alvarez CV; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 1996 Mar; 81(3):909-13. PubMed ID: 8772549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults.
    Aimaretti G; Corneli G; Razzore P; Bellone S; Baffoni C; Arvat E; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 1998 May; 83(5):1615-8. PubMed ID: 9589665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine responses to ghrelin in adult patients with isolated childhood-onset growth hormone deficiency.
    Aimaretti G; Baffoni C; Broglio F; Janssen JA; Corneli G; Deghenghi R; van der Lely AJ; Ghigo E; Arvat E
    Clin Endocrinol (Oxf); 2002 Jun; 56(6):765-71. PubMed ID: 12072046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of free fatty acids by acipimox enhances the growth hormone (GH) responses to GH-releasing peptide 2 in elderly men.
    Van Dam PS; Smid HE; de Vries WR; Niesink M; Bolscher E; Waasdorp EJ; Dieguez C; Casanueva FF; Koppeschaar HP
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4706-11. PubMed ID: 11134132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retesting young adults with childhood-onset growth hormone (GH) deficiency with GH-releasing-hormone-plus-arginine test.
    Aimaretti G; Baffoni C; Bellone S; Di Vito L; Corneli G; Arvat E; Benso L; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3693-9. PubMed ID: 11061526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated insulin levels contribute to the reduced growth hormone (GH) response to GH-releasing hormone in obese subjects.
    Lanzi R; Luzi L; Caumo A; Andreotti AC; Manzoni MF; Malighetti ME; Sereni LP; Pontiroli AE
    Metabolism; 1999 Sep; 48(9):1152-6. PubMed ID: 10484056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of growth hormone (GH) deficiency in adults with hypothalamic-pituitary disorders: comparison of test results using pyridostigmine plus GH-releasing hormone (GHRH), clonidine plus GHRH, and insulin-induced hypoglycemia as GH secretagogues.
    Hoeck HC; Vestergaard P; Jakobsen PE; Falhof J; Laurberg P
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1467-72. PubMed ID: 10770183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.